Česky
How the irradiation takes place
The Multiscan Radiology Centre Pardubice started operating the radiotherapy department in January 2003 and in March of the same year inaugurated a newly installed linear accelerator equipped with the latest technology for IMRT treatment. It continued to operate the Teragam cobalt irradiator, which was dismantled and replaced by a new linear accelerator in 2008. At the same time, the existing linear accelerator was upgraded. Since 2006, the department has been equipped with a high dose rate brachytherapy (treatment from a short or contact distance) machine. The Wolf - Medizintechnik T-200 X-ray irradiator is used for the treatment of non-cancerous diseases. The department holds a quality certificate from the German company TÜV - Rheinland (quality certificate according to ČSN EN ISO 9001:2016).
9/2019-present - Comprehensive Cancer Centre of the Pardubice Region, Multiscan s.r.o. - Head physician of Radiation Oncology
2003-2019 - Comprehensive Cancer Centre, Multiscan s.r.o. - physician
1999-present - Hospital of the Pardubice Region a.s./Pardubice Hospital - Department of Clinical and Radiation Oncology - physician (also head physician of the inpatient section)
2010-2012 - Regional Hospital Jičín - Department of Radiation Oncology - external collaborator
2012-2018 - Department of Military Radiobiology, University of Defence, doctoral studies
2005 - Specialization II. degree in radiotherapy
2002 - Specialization I. degree in radiotherapy
1994-1999 - Faculty of Medicine, Charles University in Hradec Kralove
1989-1994 - Gymnasium Holice in Bohemia
2013 ESTRO Teaching Course on Multidisciplinary Management of Breast Cancer
SROBF, ČLK, Czech Medical Society JEP, ČOS, Society of Physicians in Pardubice
Hlávka A.: Cell cycle checkpoints and their relation to carcinogenesis, Radiation Oncology, Volume 2, Issue 1, 2002, pp. 3-18
Hlávka A., Vaňásek J., Kudelka K.: Virtual simulator, Radiation Oncology, Volume 3, Issue 1, 2003, pp. 17-20
Hlávka A., Vaňásek J.: Virtual simulator - CT simulator. Conference of the Medical Society of JEP in Trutnov, 2003 - lecture
Hlávka A., Vaňásek J., Ulrych V., Klimešová M.: Cranial irradiation for brain metastases in lung cancer - evaluation of survival. XXXI. Brno Oncology Days, 2007 - lecture
Hlávka A., Ulrych V., Vaňásek J., Kudelka K., Sedláčková E.: Patient change as a radiological event - measures at our department. Symposium on Radiation Oncology, IX. Volume, 21.9. - 22.9.2012, Nový Jičín - lecture
Vanasek J., Odrazka K., Dolezel M., Kolarova I., Jarkovsky J., Pavlik T., Hlavka A., Dusek L. Statistical Analysis of Dose-Volume Profiles and its Implication for Radiation Therapy Planning in Prostate Carcinoma. Int J Radiat Oncol Biol Phys. 2013 Jul;98(7):E1241-7. doi: 10.1210/jc.2013-1113
Otahal B, Dolezel M, Cvek J, Simetka O, Klat J, Knybel L, Molenda L, Skacelikova E, Hlavka A, Feltl D: Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study. Rep Pract Oncol Radiother. 2014 May 1;19(6):399-404. doi: 10.1016/j.rpor.2014.04.005. eCollection 2014 Nov.
Vanasek J, Odrazka K, Dolezel M, Dusek L, Jarkovsky J, Hlavka A, Valentova E, Kolarova I: Searching for an appropriate image-guided radiotherapy method in prostate cancer - implications for safety margin. Tumors. 2014 Sep-Oct;100(5):518-23. doi: 10.1700/1660.18168
Dolezel M, Slezak P, Odrazka K, Vanasek J, Hlavka A, Ulrych V, Stuk J, Waczulikova I, Hartmann I: Interfraction variation in prostate cancer - analysis of 11726 cone-beam CT. J BUON. 2015 Jul-Aug;20(4): 1081-7
Vaňásek J, Kolářová I, Odrážka K, Doležel M, Hlávka A: History of prostate cancer treatment. Postgraduate medicine, 2017, vol. 19, no. 2, pp. 166-169. ISSN: 1212-4184
Kolářová I., Vaňásek J., Hlávka A., Štuk J.: Perspective on the treatment of brain metastases in patients with HER2-positive breast cancer. Postgraduate medicine, 2017, vol. 19, no. 2, pp. 152-155. ISSN: 1212-4184
Hlávka A., Vaňásek J., Odrážka K., Štuk J., Doležel M., Ulrych V., Vítková M., Mynařík J., Vilasová Z.: IGRT in patients after partial mastectomy using surgical clips - data from our department. Symposium on Radiation Oncology, XIII. June 23-24, 2017, Nový Jičín, Czech Republic
Vaňásek J, Kolářová I, Odrážka K, Doležel M, Hlávka A.: History of prostate cancer treatment. Postgraduate medicine, 2017, vol. 19, no. 2, pp. 166-169. ISSN: 1212-4184
Kolářová I., Vaňásek J., Hlávka A., Štuk J.: Perspective on the treatment of brain metastases in patients with HER2-positive breast cancer. Postgraduate medicine, 2017, vol. 19, no. 2, pp. 152-155. ISSN: 1212-4184.
Hlavka A., Vanasek J., Odrazka K., Stuk J., Dolezel M., Ulrych V., Vitkova M., Mynarik J., Kolarova I., Vilasova Z.: Tumor bed radiotherapy in women after breast conserving surgery for breast cancer - safety margin with/without image guidance. Oncology Letters 15: 6009-6014, 2018 . doi: 10.3892/ol.2018.8083
Kolářová I, Vaňásek J, Odrážka K, Hlávka A, Štuk J, Sákra L, Mergancová J: Breast cancer in the elderly. Oncology 2018; 12(6): 267-271.
Kolářová I., Vaňásek J., Odrážka K., Dušek L., Šinkorová Z., Hlávka A., Štuk J., Stejskal J., Dvořáková D., Sákra L., Mergancová J., Vilasová Z.: Are HER2-positive breast cancer subtypes relevant for clinical practice? Klin.Onkol 2019; 32(1): 25-30. doi: 10.14735/amko201925
